Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
CIPRA SA
ClinicalTrials.gov Identifier:
NCT00096681
First received: November 12, 2004
Last updated: February 17, 2011
Last verified: February 2011
Results First Received: January 14, 2011  
Study Type: Observational
Study Design: Observational Model: Ecologic or Community;   Time Perspective: Prospective
Conditions: HIV Infections
Tuberculosis

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Participants From the Community The number of participants from the community who attended the clinic for a once off study visit

Participant Flow:   Overall Study
    Participants From the Community  
STARTED     762  
COMPLETED     762  
NOT COMPLETED     0  



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Participants From the Community The number of participants from the community who attended the clinic for a once off study visit

Baseline Measures
    Participants From the Community  
Number of Participants  
[units: participants]
  762  
Age  
[units: participants]
 
<=18 years     26  
Between 18 and 65 years     726  
>=65 years     10  
Age  
[units: years]
Mean ± Standard Deviation
  30  ± 11.1  
Gender  
[units: participants]
 
Female     422  
Male     340  
Region of Enrollment  
[units: participants]
 
South Africa     762  



  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Number of Participants With Microbiologically Confirmed Pulmonary Tuberculosis   [ Time Frame: Pulmonary Tuberculosis diagnosed from sputum sample obtained at the study visit ]

2.  Secondary:   Number of Participants With a Positive HIV Test   [ Time Frame: HIV status at the time of the study visit ]


  Serious Adverse Events


  Other Adverse Events
  Hide Other Adverse Events

Time Frame No text entered.
Additional Description No text entered.

Frequency Threshold
Threshold above which other adverse events are reported   0%  

Reporting Groups
  Description
Participants From the Community The number of participants from the community who attended the clinic for a once off study visit

Other Adverse Events
    Participants From the Community  
Total, other (not including serious) adverse events    
# participants affected / at risk     0/762  



  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information